RELAPSED/REFRACTORY SOLID TUMOR
Clinical trials for RELAPSED/REFRACTORY SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY SOLID TUMOR trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo takes on tough tumors
Disease control CompletedThis phase 2 study tested a combination of two immunotherapy drugs, durvalumab and tremelimumab, in 14 adults with recurrent solid tumors that had a high number of genetic mutations. The goal was to see if the treatment could slow cancer growth compared to their prior therapy. Th…
Matched conditions: RELAPSED/REFRACTORY SOLID TUMOR
Phase: PHASE2 • Sponsor: John L. Villano, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New combo tackles Tough-to-Treat colorectal cancer
Disease control CompletedThis early-phase trial tested a combination of two drugs—copanlisib and nivolumab—in 48 adults with advanced solid tumors, specifically a type of colorectal cancer called MSS that usually doesn't respond to immunotherapy alone. The goal was to see if the combination could shrink …
Matched conditions: RELAPSED/REFRACTORY SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 26, 2026 18:01 UTC